SATisfaction and Adherence to COPD Treatment

Boehringer Ingelheim logo

Boehringer Ingelheim

Status

Completed

Conditions

Pulmonary Disease, Chronic Obstructive

Study type

Observational

Funder types

Industry

Identifiers

NCT02689492
1237.51

Details and patient eligibility

About

The present study will explore the patients satisfaction to COPD medical treatment (i.e. pharmacological and not pharmacological treatment) in a clinical real-world setting and how the satisfaction for medical treatment is related to clinical parameters, quality of life, illness perception and treatment adherence evolution. Moreover health care resource consumption will be observed during the observation period.

Enrollment

401 patients

Sex

All

Ages

40 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients aged equal or more than 40 years
  2. Patients must have a documented diagnosis of chronic obstructive pulmonary disease (COPD)
  3. Patients with no exacerbations in the last 3 months
  4. Patients requiring regular treatment according to GOLD guidelines, i.e.: undergoing stable pharmacological treatment for COPD since at least 3 months
  5. Written informed consent to both participation in the study and privacy form
  6. Patients capable of discernment and able to read or write in Italian language.

Exclusion criteria

  1. Patients who are currently participating in a clinical trial on experimental drugs.
  2. Patients naïve to pharmacological treatment for COPD
  3. Diagnosis of Asthma COPD Overlap Syndrome (ACOS)

Trial design

Trial documents
2

Trial contacts and locations

20

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems